RxDoctor Payments DataLook up a doctor →

James McWilliam, MD

Foot and Ankle Surgery · Harrison, NYNPI 1467567305

Payments from drug & device makers

$4,744,930in general payments, 2019–2025

Across 800 payments — averaging $5931.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$4.7M
  • Gotham Surgical Solutions & Devices, Inc.$5K
  • Stryker$1K
  • Treace Medical Concepts, Inc.$815
  • Integra Lifesciences Corporation$600
  • Bioventus LLC$478
  • plus $2K from 20 others
$7,125in research payments, 2019–2025

Across 1 payment — averaging $7125.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Arthrex$7K

What the payments were for

  • Royalty or licence$3,999,86384%
  • Consulting fees$227,6505%
  • Speaking & faculty fees$442,4019%
  • Travel & lodging$59,0721%
  • Food & beverage$12,1740%
  • Education$3,7690%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,744,930 in reported general payments places this provider in the 95th percentile of 652 foot and ankle surgery providers in New York.

See all foot and ankle surgery providers in New York

Medicare billing

Part B allowed, 2024
$168,741
Medicare patients
418
Services billed
2,179

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Diclofenac Sodium42$1,755
Meloxicam18$42

Paid to pharmacies, not to this prescriber.

Other foot and ankle surgery in Harrison

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →